SCHEMBL16630507

SCHEMBL16630507

CNC(=O)OC(=N)[C@@H](C)NC

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
ALDH1A1 P00352 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11786076 0.69
SCHEMBL3078435 0.69
SCHEMBL8511721 0.69
SCHEMBL18780185 0.67 CHRNB2 (0.41) CHRNB2CHRNA4ALDH1A1ACHE
SCHEMBL3074062 0.67
SCHEMBL22556956 0.66 CA14 (0.37) CHRNB2CHRNA4
SCHEMBL22556958 0.66 CA14 (0.37) CHRNB2CHRNA4
SCHEMBL21278166 0.64
SCHEMBL101667 0.63
SCHEMBL11145930 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-B1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME (US) 2019-08-21 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed